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Abstract
The female patient initially showed the acquired type of total lipoatrophy at about 8 years of
age. At 12 years of age, the onset of diabetes mellitus was speculated from advanced pyodermia
and dedentition. At 29 years of age, glucosuria was found, and she developed proteinuria, as-
cites, and pretibial edema. The physical examination revealed: hepatosplenomegaly, complete ab-
sence of subcutanous fat, cutaneous xanthomas, and emaciated facies with pronounced zygomatic
arches. Diabetic retinopathy was revealed in the ophthalmological examination, and nephropathy
was evident in renal biopsy specimens. She also had peripheral diabetic neuropathy. No adipose
tissue was found in the mesenterium under peritoneoscopy. The hepatic biopsy specimen revealed
advanced portal liver cirrhosis. Laboratory findings included: hyperlipidemia, elevation of BMR
without evidence of hyperthyroidism, impaired renal function, and undetected anti-insulin anti-
bodies and anti-insulin antibodies. Endocrinological examinations revealed normal value, except
for an impaired hGH response in the arginine test. C-peptide immunoreactivity was high. Her
condition was fairly well controlled by 140 units of insulin injection daily.
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Abstract. The female patient initially showed the acquired type of
totallipoatrophy at about 8 years of age. At 12 years of age, the onset
of diabetes mellitus was speculated from advanced pyodermia and
dedentition. At 29 years of age, glucosuria was found, and she devel-
oped proteinuria, ascites, and pretibial edema. The physical examina-
tion revealed: hepatosplenomegaly, complete absence of subcutaneous
fat, cutaneous xanthomas, and emaciated facies with pronounced zygo-
matic arches. Diabetic retinopathy was revealed in the ophthalmologi-
cal examination, and nephropathy was evident in renal biopsy speci-
mens. She also had peripheral diabetic neuropathy. No adipose tissue
was found in the mesenterium under peritoneoscopy. The hepatic
biopsy specimen revealed advanced portal liver cirrhosis. Laboratory
findings included: hyperlipidemia, elevation of BMR without evidence
of hyperthyroidism, impaired renal function, and undetected anti-insulin
antibodies and anti-insulin receptor antibodies. Endocrinological ex-
aminations revealed normal value, except for an impaired hGH re-
sponse in the arginine test. C-peptide immunoreactivity was high. Her
condition was fairly well controlled by 140 units of insulin injection
daily.
Key words: lipoatrophic diabetes, diabetic triopathy,
hepatosplenomegaly, anti-insulin receptor antibodies,
CPR
Lipoatrophic diabetes was first described in 1946 by Lawrence (I). This
syndrome was defined by the following characteristics; (a) complete absence of
subcutaneous and intra-abdominal fat; (b) insulin-resistant diabetes with little
tendency to develop ketosis; (c) hepatosplenomegaly; (d) hyperlipemia with
cutaneous xanthoma; and (e) marked elevation of BMR without evidence of
hyperthyroidism. After this initial report, other cases were found and much
discussion followed on the mechanism and patho-etiology. In Japan, more than
10 lipoatrophic diabetes cases were reported, and several attempts were made to
examine the "diabetogenic peptide" characteristics. W~ describe here a patient
with all major characteristics of lipoatrophic diabetes simultaneously with diabet-
ic complications.
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CASE REPORT
The patient was a 32-year-old Japanese female, who had no diabetic or
parental consanguinity in her family. Her birth was full term, without notice-
able abnormality. At 8 years of age, she gradually became emaciated. At 12
years of age, she began to show dedentition due to alveolar pyorrhea. At the
same time, pyodermia was evident in the abdomin.3.l wall and buttocks. There
was no evidence of polyphagia, polydipsia, and polyuria until she was 29 years of
age, when glucosuria was found. Diabetes mellitus was diagnosed, and she was
treated with tolbutamide, At 31 years of age, she developed proteinuria, hyper-
tension, and pretibial edema. Several months later, ascites and increased pretibial
Fig. 1. Photograph of patient at 31 years of age.
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edema, hepatosplenomegaly, and cardiomegaly were noted. Her diabetic state
was difficult to control by insulin. At this point, she was referred to us for con-
sultation.
Physical examination on admission. The patient was 143 cm tall and weighed
41 kg. Her blood pressure was 140/88 mmHg. She had emaciated facies with
pronounced zygomatic arches and was lacking subcutaneous adipose tissue, except
for the breast (Fig. 1). The musculatures were prominent. Numerous, wide-
spread cicatrical keroids were observed on the abdominal wall and hip regions.
She had hyperpigmented skin and acanthosis nigricans was present in the axillae.
Her hair was curly enough but scanty in the axillary and public areas. Xantho-
mas were evident on the left upper eyelid and in the posterior cervical region.
The parotid glands were not enlarged. Almost complete dedentition resulted
from alveolar pyorrhea. The liver edge was felt 3cm below the right costal
margin. The spleen was felt 2cm below the left costal margin. Genitalia was
almost normal, except for mild enlargement of the clitoris. In the lower ex-
tremities, reflexes were absent, and marked phlebomegaly was present.
Fig. 2. Fluorescent funduscopy. Numerable microaneurysmas
and leakages are seen.
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On funduscopy, the disk appeared normal, but the retina showed marked
changes with cotton-wool patches and had hemorrhages. By fluorescent fundus-
copy, numerable microaneurysmas and leakages were present bilaterally (Fig. 2).
On peritoneoscopy, no adipose tissue was found in the mesenterium and
greater omentum. The liver was cirrhotic, and venous dilatation was seen in the
portal vein system.
Roentgenograms. Chest x-ray film showed the prominence of the left ventri-
cle. On x-ray films of the skull, the sella turcica was normal in shape and size.
X-ray films of the bilateral arms showed marked calcification in the osseous cor-
tices. Pelvic films showed calcification of the femoral arteries.
Biopsy specimens. Diabetic glomerulosclerosis was seen on kidney tissue ob-
tained by percutaneous needle biopsy. Fluorescent antibody technique on the
kidney revealed linear staining along the glomerular basement membrane with
FITC labelled anti-IgG serum (Fig. 3). Skin biopsy revealed an absence of sub-
cutaneous fat. The hepatic biopsy specimen revealed advanced portal liver cir-
rhosis (Fig. 4).
A. Diabetic glomerulosclerosis. PAS stain, X 400.
B. Linear staining along the glomerular basement
membrane with FITC labelled anti-IgG serum.
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Fig. 4. Advance changes in portal liver cirrhosis. HE stain X 400.
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Laboratory findings. Serum electrolytes, blood urea nitrogen, serum crea-
tinine, and the blood picture were within normal limits. The 24-h urinary
excretion of glucose ranged from 1J to 20g and protein from 0.5 to 1.5g. Total
serum protein was 7.4 g/dl, and the electrophoretic pattern showed: albumin
47.1 %, alphal-globulin 2.9 %, alphaz-globulin 11.5 %, beta-globulin 17.3 %, and
gamma-globulin 21.2%. Liver function test indicated: serum GOT, 41 u; serum
GPT, 65 u; serum Al-p, 4.0 B.L.u; and 25.8% indocyanine green retention in
15 min. Serum lipid values were: NEFA, 720 ,uEq/l; phospholipid, 244 mg/dl;
triglyceride, 196 mg/dl; and total cholesterol, 275 mg/dl. The creatinine clear-
ance was 65.1 ml/min. PSP test showed 37.5% excretion in 30 min, 39.8% in
60 min, and 43.5% in 120 min.
In serological tests, anti-insulin antibodies were negative, and anti-insulin
receptor antibodies (kindly assayed by Dr. J.S. Flier of NIH, USA) were not
detected. Serologic tests for syphilis were negative; RA tests were negative;
anti-nuclear antibodies were negative; anti-thyroglobulin antibodies were nega-
tive; and serum complement titer (CH50) was 44 (normal). Immunoglobulin
values were: IgG, 1400 mg/dl; IgA, 650 mg/dl; and IgM, 200 mg/dl.
The electroencephalogram was interpreted within normal limits. The in-
telligence test revealed mild mental retardation. Cerebrospinal fluid on lumbar
puncture revealed no abnormality, except for high glucose level.
Thyroid function studies showed: BMR, + 35 %; T 3-resin sponge uptake,
23%; and T 4 (total), 5.0,ug/dl. In examination of the hypophysio-adrenocor-
tical axis, the LH-RH test and TRH test were within normal. Human growth
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hormone (hGH) revealed a hyperresfXJnse to insulin, and no resfXJnse to arginine
(Table 1).
TABLE 1. PATIENT DATA ON ENDOCRINOLOGICAL PARAMETERS
Plasma cortisol Growth hormone
Diurnal variation
Time flg/dl
Insulin test (0.1 U/kg iv)
Minutes ng/ml
_._-----_ .._----
9am
4pm
11 pm
8.0
7.2
7.5
o
30
60
90
4. 7
80
13.0
7.8
Initial
Terminal
LH-RH test (0.1 mg LH-RH iv)
3.9
2.6
3.9
2.4
4.2
10.5
12.5
15.0
15.5
11. 0
9.0
TSH
flU/ml
o
15
30
45
60
90
120
o
30
60
120
Minutes
Arginine test
0.5 g/kg 30 min iv infusion)
Minutes ng/m1
TRH test (0.5 mg TRH iv)
ACTH test
(004 mg synthetic ACTH)
Minutes flg/d1
o 1. 25
30 10.0
60 13.8
Overnight dexamethasone sup-
pression test (dexamethasone
1mg orally)
Time flg/ d1
----~--_.
8.0
1. 25
Minutes LH FSH(mIU/m1) (mIU/m1)
0 12.0 22.8
15 25.0 26.0
30 37.5 27.0
60 32.9 27.0
90 29.0 30.0
Urine 17 KS 1O.1Omg/day
Urine 170HCS 5.72 mg/day
Blood glucose and C-peptide immunoreactivity (CPR) levels during 50 g
GTT are shown in Fig. 5. A 'diabetic pattern was evident, and the CPR level
revealed a high basal value. In the tolbutamide test (Fig. 6), CPR showed a good
resfXJnse with high basal value, but blood glucose showed a delayed response.
In the arginine test (Fig. 7), CPR level was well correlated to the blood glucose
level. The blood glucose concentrations following intravenous administration of
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Fig. 5. Blood glucose (solid line) and C-peptide immunoreactivity (CPR) (broken line)
levels during 50g GTT. Blood glucose values showed a diabetic pattern, and high CPR level
was observed.
Fig. 6. Blood glucose (solid line) and C-peptide immunoreactivity (CPR) (broken line)
levels after intravenous injection of I g tolbutamide. Tolbutamide evocked a high CPR level
and delayed lowering of blood glucose level.
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Fig. 7. Blood glucose (solid line) and C-peptide immunoreactivity (CPR) (broken
line) levels during arginine (0.5 g/kg) infusion. The CPR level was well correlated to
the blood glucose level.
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regular insulin (1 unit/kg) were: 272 mg/dl at 0 min, 172 mg/dl at 30 min,
122mg/dl at 60min, 110mg/dl at gO min, and l06mg/dl at l20min. Post-
heparin lipolytic activity was markedly decreased: below 0.01 rEq FFA/ml/min
at 10, 20 and 30 min.
Clinical course. The patient was fed 1,200 calories (1 EO g carbohydrate, 6D g
protein, 30 g fat) daily after admission. On admission, fasting blood glucose
(FBG) was 240 mg/dl and the 24 h urinary glucose was 10 g; then 12 units NPH
insulin was administered for 60 days. In the meantime, the patient had an
episode of urinary tract infection due to atonic bladder. Cephalexin at 1g daily
was administered, but an adverse reaction appeared in the liver. In spite of
improvement in serum GOT, GPT, and Al-p levels, severe glucose intolerance
was found. Though NPH insulin was increased to 100 units daily, FBG was
still about 300 mg/dl, and the 24 h urinary glucose output was about 50 g.
After increasing NPH insulin to 140 units daily, she showed fairly good control
of FBG decreasing to about 170 mg/dl. Pimozide administration was attempted
for 40 days starting with an initial dose of 1mg daily and ending with 4 mg daily.
No effect was obvious on the symptoms. She experienced recurrent exacerbation
of chronic pyodermia and chronic cystitis throughout her hospitalization period.
DISCUSSION
This patient had all the characteristics of acquired lipoatrophic di3.betes.
The lipodystrophy might have occurred at 8 years of age, followed later by the
onset of diabetes mellitus that was suspected by the advanced dedentition and
pyodermia. This patient was referred to us as insulin resistant diabetes, but on
admission, the condition was fairly well controlled by 12 units NPH insulin and
diet control. She developed severe glucose intolerance after an episode of liver
injury. After increasing the dose of insulin to 140 units daily, the diabetes was
again fairly well controlled. The patient also had retinopathy, neuropathy, and
nephropathy as complications. Many investigators have reported the tendency
for diabetic complications, especially in a poorly control situation (2). Podolsky
(3) reported I! nephropathy cases out of 64 cases with lipoatrophic diabetes.
Sato and his colleagues (4) reported three retinopathy out of five lipoatrophic
diabetes cases.
Many recent reports have related the pathogenesis of lipoatrophic diabetes
to hypothahmic derangement. Seip (5) reported a widening of the basal cistern
and third ventricle by pneumoencephalography in several patients. In the same
report, Seip described the lipid center in the anterio-inferior hypothalamus of dog
with hyperlipemia and decreased adipose tissue.
In endocrinological studies, several investigators (6) have reported impaired
hGH response in several tests. In our case, tests of the hypophysio-adrenocortical
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axis, LH-RH test and TRH tests were within normallimits. The hGH levels
indicated a hyperresponse to insulin and no response to arginine.
In 1963 Louis and his colleagues (7) found a peptide of insulin antagonist in
the urine of patients with lipoatrophic diabetes. This peptide made dogs insensi-
tive to insulin and intolerant to glucose. They called this peptide diabetogenic
peptide which was secreted from the pituitary body and probably had a patho-
genetic role in the condition. This substance is difficult to extract and define, and
was not always detected in patients. In our study here, we were not able to
detect this substance. Pimozide, a cerebral dopaminergic blocking agent, could
possibly correct the diencephalon-hypothalamic abnormality. In 1974, Corbin
et al. (8) reported several lipodystrophy cases improving after pimozide adminis-
tration. In our case, we could not determine its efficacy.
Kahn et al. (9) reported cases with a syndrome of insulin resistance and
acanthosis nigricans, and divided these cases into two types: Type A, a syn-
drome in younger females with signs of virilization or accelerated growth, in
whom the receptor defect might be primary, and Type B, a syndrome in older
females with signs of an immunologic disease, in whom circulating antibodies to
insulin receptor were found. In Type A patients many features were similar to
those in lipoatrophic diabetes. However, Type A patients did not have lipo-
atrophy, hyperlipidemia, or hepatomegaly. Oseid and his colleagues (10) re-
ported four cases with congenital generalized lipodystrophy with extreme insulin
resistance. In their patients, mononuclear leukocytes bound significantly less
insulin than normal subjects after 12 h of fasting. After 60 h of fasting, insulin
binding increased, and this rise was followed by decreased plasma insulin level.
These phenomena suggest a possible reversal of the receptor defect, which argues
against a primary receptor defect and indicates changes in receptor number.
However, Scatchard analysis suggested a decrease in binding affinity in cells
of these patients. These investigators suggested that the interference of recep-
tor antibodies might also be the cause of receptor abnormality in congenital
generalized lipodystrophy. Rosenbloom et al. (11) tested insulin binding to cul-
tured fibroblasts of lipoatrophic diabetes patients and found that the cells of these
patients did not differ significantly on any characteristic from normal control
subjects. These findings indicated that a basic defect is not present in insulin
receptors of lipoatrophic diabetes. These same investigators mentioned that a
secondary disruption of binding, e.g., by a circulating factor remained possible.
In our case, the basal CPR level was high, and anti-insulin antibodies and anti-
insulin receptor antibodies were not detected. Further investigations on insulin
receptor abnormalities in lipoatrophic diabetes will be attempted in the future.
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